Drugs / LMP1/2 CTLs
LMP1/2 CTLs
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01956084 | Nov 2013 → Nov 2017 | Hodgkins lymphoma, leiomyosarcoma, lymphoepithelial-like carcinoma, non-Hodgkin lymphoma | Catherine Bollard | Completed | No outcome recorded |
| Phase 1 | NCT00516087 | Aug 2007 → Dec 2012 | nasopharyngeal carcinoma | Baylor College of Medicine | Completed | No outcome recorded |
| Phase 1 | NCT00515957 | Aug 2007 → Aug 2010 | nasopharyngeal carcinoma | Baylor College of Medicine | Withdrawn | No outcome recorded |
| Phase 1 | NCT00062868 | Sep 2003 → Apr 2014 | Hodgkins lymphoma, leiomyosarcoma, lymphoepithelial-like carcinoma, non-Hodgkin lymphoma | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LMP1/2 CTLs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01956084 ↗ |
| Known as | LMP-Ts | “allogeneic donor-derived LMP-specific T cells (LMP-Ts) have not been established for patients who have undergone allogeneic hematopoietic stem-cell transplantation (HSCT).” PMID 30262660 ↗ Sep 2018 |
| Known as | LMP1- and LMP2- specific cytotoxic T-lymphocytes | “new experimental therapy consisting of special immune system cells called LMP1- and LMP2-specific cytotoxic T lymphocytes (LMP1- and LMP2-CTLs)” NCT00516087 ↗1“LMP1- and LMP2- specific cytotoxic T-lymphocytes (CTL) in combination with CD45 monoclonal antibody (MAb).” NCT00515957 ↗ |
| Known as | LMP1- and LMP2-CTLs | “These special T cells are called LMP1- and LMP2-CTLs.” NCT00516087 ↗ |
| Known as | LMP1- and LMP2-specific T cells | “LMP1- and LMP2-specific T cells will be given by intravenous injection over 1-10 minutes through either a peripheral or a central line.” NCT00516087 ↗ |
| Modality | Cell therapy | “the ALCI product continued to be a CTL line specific for EBV antigens” NCT00062868 ↗ |
| Route | Other | “the cells will then be thawed and injected into the patient over 10 minutes” NCT00062868 ↗ |